Balixafortide
- Generic Name
- Balixafortide
- Drug Type
- Biotech
- CAS Number
- 1051366-32-5
- Unique Ingredient Identifier
- PRC974M49B
- Background
Balixafortide is under investigation in clinical trial NCT03786094 (Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath